SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001144204-19-025257
Filing Date
2019-05-10
Accepted
2019-05-10 16:01:20
Documents
1
Period of Report
2019-03-31
Effectiveness Date
2019-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 12B-25 tv521267_nt10q.htm NT 10-Q 24967
  Complete submission text file 0001144204-19-025257.txt   26104
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-36150 | Film No.: 19814762
SIC: 8731 Services-Commercial Physical & Biological Research